Dr. Christian Bentley is the Cardiometabolic Outcomes Reviewer at GLPOneMedical. He is the lead reviewer for cardiovascular outcome trial content — most notably the SELECT trial (basis for the March 2024 Wegovy CV indication) and the SURPASS-CVOT program that is expected to read out in 2026 for tirzepatide.
Background
Dr. Bentley is a board-certified physician in internal medicine and cardiology, with subspecialty interest in preventive cardiology and the cardiovascular complications of metabolic disease. His clinical focus has been the long-term cardiovascular care of patients with established CVD and concurrent obesity, T2D, or dyslipidemia.
Role at GLPOneMedical
As Cardiometabolic Outcomes Reviewer, Dr. Bentley:
- Reviews all pages related to cardiovascular outcomes, MACE reduction, and the Wegovy CV indication.
- Is the lead reviewer for the SELECT trial summary and the SELECT-aligned guidance content.
- Reviews the REWIND (dulaglutide CV), LEADER (liraglutide CV), and forthcoming SURPASS-CVOT (tirzepatide CV) trial summary pages.
- Reviews insurance-coverage pages that touch on the CV indication, including Medicare Part D coverage expansion content.
- Reviews who-it's-for pages relevant to CV risk demographics (men 40+, postmenopause, established CVD).
Areas of expertise
- Cardiovascular outcome trial design — MACE-3 vs MACE-4, primary prevention vs secondary prevention, time-to-event analysis.
- Preventive cardiology — lipid management, BP, glycemic control, obesity as CV risk factor.
- The SELECT findings — 20% MACE reduction in obesity + established CVD without diabetes, what it means clinically.
- Insurance landscape for CV indications — the regulatory and coverage rationale for the March 2024 Wegovy approval and the April 2026 Part D expansion.
Recent reviews signed off
- SELECT trial summary
- GLP-1 and cardiovascular disease
- Medicare Part D Wegovy expansion
- GLP-1 for men over 40
Conflicts of interest
None disclosed beyond the standard editorial-retainer arrangement with Ranika Partners LLC. No advisory or compensation relationships with any provider reviewed on this site. Full conflicts disclosure: /conflicts-of-interest.html.
Contact
glponemedical@gmail.com (subject line: "Medical advisory board / Dr. Bentley").